SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hanson Bryan Michael

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

92121

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP Global Port. Mgmt & Mkting

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	900	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Options	⁽¹⁾	08/22/2027	Common Stock	188	$92.23	D
Incentive Stock Options	⁽¹⁾	08/22/2027	Common Stock	282	$92.23	D
Incentive Stock Options	⁽¹⁾	12/20/2029	Common Stock	1,050	$119.06	D
Incentive Stock Options	⁽¹⁾	08/21/2030	Common Stock	420	$119.06	D
Incentive Stock Options	⁽¹⁾	03/18/2032	Common Stock	291	$179.06	D
Incentive Stock Options	⁽¹⁾	03/18/2032	Common Stock	291	$179.06	D
Non-Qualified Stock Options	⁽¹⁾	12/20/2029	Common Stock	1,050	$119.06	D
Non-Qualified Stock Options	⁽¹⁾	08/21/2030	Common Stock	420	$119.06	D
Non-Qualified Stock Options	⁽²⁾	04/26/2033	Common Stock	4,377	$88.67	D
Non-Qualified Stock Options	⁽³⁾	04/22/2034	Common Stock	10,522	$39.08	D
Non-Qualified Stock Options	⁽⁴⁾	07/01/2035	Common Stock	17,392	$29.79	D
Non-Qualified Stock Options	⁽⁵⁾	01/30/2036	Common Stock	36,150	$27.17	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock	1,459	⁽⁷⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	446	⁽⁷⁾	D
Restricted Stock Units	⁽⁹⁾	⁽⁹⁾	Common Stock	7,016	⁽⁷⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	17,392	⁽⁷⁾	D
Restricted Stock Units	⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	36,152	⁽⁷⁾	D

Explanation of Responses:

1. Vested in full.

2. 2,918 shares are vested in full; the remaining 1,459 shares will vest on April 26, 2026.

3. 3,507 shares are vested in full; 3,507 shares will vest on April 22, 2026 and 3,508 shares will vest on April 22, 2027.

4. 5,797 shares will vest on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028.

5. 36,150 shares will vest in equal installments on January 30, 2027, January 30 ,2028 and January 30, 2029.

6. 1,459 shares will vest on April 26, 2026.

7. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

8. 446 shares will vest on August 15, 2026.

9. 7,016 shares will vest in equal installments on April 22, 2026 and April 22, 2027.

10. 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

Remarks:

This Form 3 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes

	/s/ Euna Greene, attorney-in-fact for Bryan M. Hanson	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.